Panacea Biotec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve the Audited Financial Results ....
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec has informed stock exchanges that its Board of Directors will meet on May 30, 2025, in New Delhi. The main agenda is to consider and approve the audited financial results (both standalone and consolidated) for Q4 and the full financial year ended March 31, 2025. The Board may also discuss skipping dividend on both equity and preference shares for the year. The company's trading window remains closed for designated persons until June 1, 2025, and reopens on June 2, 2025.
This is a routine regulatory filing ahead of results. Investors should watch the May 30 announcement closely for actual earnings numbers and clarity on whether the dividend will be skipped, which would suggest cash conservation.